adherence

Views & Analysis
Health-Prize-Technologies_banner_570x320

Non-adherence: pharma’s final financial frontier

No other industry would tolerate avoidable annual losses of $637 billion, but that’s exactly what pharma is doing by not investing in adherence. Now is the time to start recovering that revenue.